Clinical Trials in Philadelphia

Showing 2501-2520 of 9,968 trials

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

NCT05748158

The goal of this clinical trial is to determine the physiological basis for the differences in weight regain among adults (25-59 years old) with obesity following participation in a behavioral weight loss program. Eligible participants will undergo a baseline evaluation after which they will enter an up to 20 week behavioral weight loss program with the goal of losing at least 7 percent of their baseline weight within 35 weeks. Participants who meet the weight loss goal will be asked to remain weight stable for 2 weeks after which they will undergo a clinical examination. They will then be observed for 1 year during which they will undergo 2 additional clinical examinations, one 4 months after completing the weight loss program, and the other 12 months after completing the weight loss program.

Obesity

University of Pittsburgh205 participantsStarted Sep 2023

New York, New York, United States • Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States

RECRUITING< 1 mile

EluPro Antibiotic-Eluting BioEnvelope Registry

NCT06854081

A Multi-Center Registry Study Evaluating Participants Who Receive EluPro Antibiotic-Eluting BioEnvelope During CIED Implantation

Cardiac Arrhythmias

Elutia Inc.100 participantsStarted Apr 2025

La Jolla, California, United States • Tallahassee, Florida, United States • Boston, Massachusetts, United States +1 more locations

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

EluPro Antibiotic-Eluting BioEnvelope Registry

Find Trials by Condition in Philadelphia

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)

BCAAs in Concussion 2.0

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Shared-Decision Making for Hydroxyurea

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies